Tumor Size Is a Critical Factor in Adjuvant Chemotherapy for T_3-4aN0M0 Gastric Cancer Patients after D2 Gastrectomy

Table 3

Multivariate analyses of overall survival in gastric cancer patients (Cox’s regression model).

Variable	HR	95% CI	value
OS in gastric cancer patients
Tumor size	2.780	1.894–4.081	<0.001
CEA level	0.936	0.510–1.717	0.831
Tumor location	1.221	1.023–1.458	0.027
Pathological T staging	2.101	1.342–3.289	0.001

OS, overall survival; HR, hazard ratio; CI, confidence interval.